Scientists at the University of Oxford demonstrate an approach to interpreting how materials interact with polarized light, ...

Non-terrestrial networks, combined with early 6G research, demand test equipment capable of handling extreme parameters and ...

Phase 1a/1b study in 97 patients demonstrates mitochondrial metabolic reprogramming induced by BPM31510-IV and supports advancement in multiple ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...

Elliptical retarder model improves polarization analysis for material design and biomedical imaging. The work, reported in Advanced Photonics Nexus, focuses on improving how researchers analyze a key ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, today ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

Multi-electrode arrays (MEAs) provide a noninvasive interface with sub-millisecond temporal resolution and long-term, ...

Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment ...

Scientists at the University of Oxford demonstrate an approach to interpreting how materials interact with polarized light, which could help advance ...